Bridges Investment Counsel’s Allergan plc AGN Stock Holding History
Bought
Maintained
Sold
Other funds holding AGN
BG
Bridges Investment Counsel's AGN Position: Q4 2017 in Review
Bridges Investment Counsel reduced its Allergan plc (AGN) stake by 8.9% in Q4 2017, selling an estimated $87.9K and leaving 5,032 shares worth $823K. The position accounts for 0.45% of the portfolio, ranked #61.
Bridges Investment Counsel first reported a position in AGN in Q2 2013 and has held it in 19 quarters since. The position peaked at $9.8M in Q4 2015. 1,048 funds tracked by Wall St. Rank hold AGN as of Q4 2017.
- Bridges Investment Counsel held 5,032 shares of Allergan plc worth $823K as of Q4 2017.
- Bridges Investment Counsel sold 490 Allergan plc shares in Q4 2017, an estimated $87.9K.
- Allergan plc made up 0.45% of Bridges Investment Counsel's portfolio in Q4 2017, its #61 holding.
- Bridges Investment Counsel first reported a position in Allergan plc in Q2 2013 and has held it in 19 quarters since.
- Bridges Investment Counsel's Allergan plc position peaked at $9.8M in Q4 2015.
- 1,048 funds tracked by Wall St. Rank held Allergan plc as of Q4 2017.
Based on Bridges Investment Counsel's 13F filing for Q4 2017, filed 9 Feb 2018.